（1）Nguyen KH, Ande SR, Mishra S. Prohibitin: an unexpected role in sex dimorphic functions. Biol Sex Differ 2016; 7: 30.
（2）Ande SR, Nguyen KH, Gregoire Nyomba BL, Mishra S. Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC. Sci Rep 2016; 6: 23608.
（3）Mishra S, Nyomba BL. Prohibitin—at the crossroads of obesity-linked diabetes and cancer. Exp Biol Med (Maywood) 2017; 242: 1170–1177.
（4）Nguyen KH, Ande SR, Mishra S. Obesity-related abnormalities couple environmental triggers with genetic susceptibility in adult-onset T1D. Biochem Biophys Res Commun 2016; 470: 94–100.
（5）Ande SR, Nguyen KH, Padilla-Meier GP, Wahida W, Nyomba BL, Mishra S. Prohibitin overexpression in adipocytes induces mitochondrial biogenesis, leads to obesity development, and affects glucose homeostasis in a sex-specific manner. Diabetes2014; 63: 3734–3741.
（6）Ande SR, Nguyen KH, Nyomba BL, Mishra S. Prohibitin in adipose and immune functions. Trends Endocrinol Metab 2016; 27: 531–541.
（7）Ande SR, Mishra S. Nuclear coded mitochondrial protein prohibitin is an iron regulated iron binding protein. Mitochondrion 2011; 11: 40–47.
（8）Mishra S, Ande SR, Nyomba BL. The role of prohibitin in cell signaling. FEBS J 2010; 277: 3937–3946.
（9）Mishra S, Ande SR, Salter NW. O-GlcNAc modification: why so intimately associated with phosphorylation? Cell Commun Signal2011; 9: 1.